Neuberger Berman High Yield Strategies Fund Inc. - Common (NHS)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NHS on NYSE
Type / Class
Equity / Common
Shares outstanding
25,928,040
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3,517,239
Holdings value
$26,382,730
% of all portfolios
0%
Number of holders
42
Number of buys
25
Number of sells
-17
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Neuberger Berman High Yield Strategies Fund Inc. - Common (NHS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FIRST TRUST PORTFOLIOS LP 21.07% $40,972,785 5,463,038 First Trust Portfolios L.P. 30 Sep 2025

Institutional Holders of Neuberger Berman High Yield Strategies Fund Inc. - Common (NHS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3,517,239 $26,382,730 +$495,251 $7.5 42
2025 Q2 3,491,829 $26,468,334 +$1,080,688 $7.58 41
2025 Q1 3,348,962 $25,585,156 -$1,086,455 $7.64 37
2024 Q4 3,496,030 $26,184,281 +$86,615 $7.49 38
2024 Q3 3,439,678 $29,821,095 +$3,803,052 $8.67 31
2024 Q2 3,013,753 $23,567,250 -$2,063,559 $7.82 37
2024 Q1 3,277,616 $26,412,474 -$4,048,383 $8.06 34
2023 Q4 3,825,628 $29,550,571 +$5,108,200 $7.72 43
2023 Q3 3,164,936 $23,832,932 -$578,050 $7.53 40
2023 Q2 3,186,083 $23,862,884 +$4,780,183 $7.49 45
2023 Q1 2,532,587 $21,624,370 -$1,585,785 $8.52 42
2022 Q4 2,721,500 $23,187,122 -$3,797,493 $8.52 40
2022 Q3 3,122,618 $24,685,000 -$3,036,027 $7.9 42
2022 Q2 3,482,821 $29,175,000 +$14,275,121 $8.38 47
2022 Q1 1,745,583 $19,934,000 -$1,134,091 $11.42 35
2021 Q4 1,875,310 $23,310,000 +$48,144 $12.43 39
2021 Q3 1,950,683 $24,696,000 -$5,635,444 $12.67 36
2021 Q2 2,293,072 $30,431,000 -$973,183 $13.27 33
2021 Q1 2,366,644 $30,500,942 -$3,919,066 $12.89 32
2020 Q4 2,649,681 $30,977,000 -$52,750,428 $11.69 41
2020 Q3 7,437,139 $82,486,000 -$336,786 $11.09 39
2020 Q2 7,426,903 $76,867,000 +$5,122,927 $10.35 39
2020 Q1 7,016,317 $60,899,000 +$3,377,209 $8.68 46
2019 Q4 6,509,013 $80,383,000 -$5,997,634 $12.35 43
2019 Q3 6,902,626 $83,309,000 -$14,122,984 $12.07 41
2019 Q2 8,104,028 $94,818,000 -$3,317,473 $11.7 46
2019 Q1 8,390,420 $94,728,000 +$11,447,463 $11.29 46
2018 Q4 7,504,385 $72,644,000 +$2,929,965 $9.67 48
2018 Q3 7,173,474 $78,550,975 +$11,439,144 $10.95 54
2018 Q2 6,026,925 $65,248,000 +$7,046,324 $10.82 50
2018 Q1 5,375,282 $59,905,000 +$1,891,140 $11.14 44
2017 Q4 5,205,594 $61,215,000 +$1,665,194 $11.76 37
2017 Q3 4,982,085 $60,578,000 +$3,036,535 $12.16 39
2017 Q2 4,743,121 $56,400,285 -$900,742 $11.89 47
2017 Q1 4,819,238 $57,223,699 +$1,368,194 $11.88 46
2016 Q4 4,645,951 $54,198,000 +$2,294,653 $11.67 44
2016 Q3 4,450,135 $52,720,164 -$2,477,866 $11.86 43
2016 Q2 4,690,596 $51,345,000 -$6,907,053 $10.95 50
2016 Q1 5,322,364 $56,366,284 -$2,190,503 $10.61 45
2015 Q4 5,586,950 $56,375,000 -$4,372,227 $10.09 45
2015 Q3 6,033,575 $61,444,000 +$857,185 $10.19 44
2015 Q2 5,896,038 $69,425,732 +$5,174,699 $11.78 43
2015 Q1 5,409,971 $66,580,224 +$870,542 $12.34 44
2014 Q4 5,255,050 $64,405,835 +$6,079,600 $12.3 48
2014 Q3 4,688,715 $60,532,025 +$3,197,091 $12.91 41
2014 Q2 4,423,959 $61,269,147 +$7,923,112 $13.85 44
2014 Q1 3,826,354 $52,118,652 +$3,543,254 $13.62 32